QW, R., & KH, Y. (2026). Glucagon-like peptide-1 analogues and prevention of atrial fibrillation: Clinical and mechanistic insights. European journal of preventive cardiology, 33(1), 42. https://doi.org/10.1093/eurjpc/zwaf242
Chicago Style (17th ed.) CitationQW, Ren, and Yiu KH. "Glucagon-like Peptide-1 Analogues and Prevention of Atrial Fibrillation: Clinical and Mechanistic Insights." European Journal of Preventive Cardiology 33, no. 1 (2026): 42. https://doi.org/10.1093/eurjpc/zwaf242.
MLA (9th ed.) CitationQW, Ren, and Yiu KH. "Glucagon-like Peptide-1 Analogues and Prevention of Atrial Fibrillation: Clinical and Mechanistic Insights." European Journal of Preventive Cardiology, vol. 33, no. 1, 2026, p. 42, https://doi.org/10.1093/eurjpc/zwaf242.